<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Types of cutaneous vasculitis&lt;SUP&gt;[1]&lt;/SUP&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Types of cutaneous vasculitis<sup>[1]</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Types of cutaneous vasculitis<sup>[1]</sup></div><div class="cntnt"><table cellspacing="0"><colgroup span="12" width="8%"></colgroup> <tbody> <tr> <td class="subtitle1"> </td> <td class="subtitle1">PAN</td> <td class="subtitle1">c-PAN</td> <td class="subtitle1">NV</td> <td class="subtitle1">GP<br/> (WG)</td> <td class="subtitle1">EGP<br/> (CSS)</td> <td class="subtitle1">MPA</td> <td class="subtitle1">CV</td> <td class="subtitle1">RV</td> <td class="subtitle1">IgA<br/> (HSP)</td> <td class="subtitle1">UV</td> <td class="subtitle1">CSVV</td> </tr> <tr class="divider_bottom"> <td><strong>Vessel size</strong></td> <td>Medium</td> <td>Medium</td> <td>Medium</td> <td>Medium and small</td> <td>Medium and small</td> <td>Medium and small</td> <td>Medium and small</td> <td>Medium and small</td> <td>Small</td> <td>Small</td> <td>Small</td> </tr> <tr class="divider_bottom"> <td><strong>Cutaneous findings</strong></td> <td>Nodules, ulcers, livedo racemosa, infarcts</td> <td>Nodules, ulcers, livedo racemosa</td> <td> <p>Nodules, ulcers</p> <p>Lower extremity edema</p> </td> <td> <p>Nodules, ulcers, livedo racemosa, infarcts, palpable purpura</p> <p>Saddle nose deformity</p> <p>Strawberry gums</p> </td> <td>Nodules, ulcers, livedo racemosa, infarcts, palpable purpura</td> <td>Nodules, ulcers, livedo racemosa, infarcts, palpable purpura</td> <td>Nodules, ulcers, livedo racemosa, infarcts, palpable purpura</td> <td>Nodules, ulcers, livedo racemosa, infarcts, palpable purpura</td> <td>Urticarial papules, purpura, petechiae</td> <td>Urticarial papules, purpura, petechiae</td> <td>Urticarial papules, purpura, petechiae</td> </tr> <tr class="divider_bottom"> <td><strong>Systemic symptoms/involvement</strong></td> <td> <p>Weight loss, myalgia, fatigue, neuropathy, hypertension</p> <p>Decreased renal perfusion</p> </td> <td>Weight loss, myalgia, fatigue, neuropathy</td> <td>Tuberculosis</td> <td> <p>Weight loss, myalgia, fatigue, neuropathy</p> <p>Glomerulonephritis</p> <p>Necrotizing granulomatous inflammation of respiratory tract</p> </td> <td> <p>Weight loss, myalgia, fatigue, neuropathy</p> <p>Allergies</p> <p>Asthma</p> <p>Heart and GI involvement (especially if p-ANCA -)</p> <p>Glomerulonephritis and neuropathy (especially if p-ANCA +)</p> </td> <td> <p>Weight loss, myalgia, fatigue, neuropathy</p> <p>Alveolar hemorrhage</p> <p>Glomerulonephritis</p> </td> <td> <p>Weight loss, myalgia, fatigue, peripheral neuropathy</p> <p>Membranoproliferative glomerulonephritis</p> </td> <td> <p>Weight loss, myalgia, fatigue, neuropathy</p> <p>Deforming arthritis</p> </td> <td>Arthritis, abdominal pain, renal involvement</td> <td>Fever, angioedema, arthralgias, abdominal pain, Raynaud phenomenon, uveitis, obstructive lung disease</td> <td>Fatigue</td> </tr> <tr class="divider_bottom"> <td><strong>Helpful lab/study findings</strong></td> <td>Negative ANCAs</td> <td>Negative ANCAs</td> <td> <p>PPD</p> <p>CXR</p> </td> <td> <p>+c-ANCA</p> <p>+PR3</p> </td> <td> <p>+p-ANCA</p> <p>+MPO</p> <p>Eosinophilia</p> </td> <td> <p>+p-ANCA</p> <p>No eosinophilia</p> </td> <td> <p>Hepatitis C+ plus cryoglobulins</p> </td> <td>High titer rheumatoid factor</td> <td>Urinalysis looking for renal involvement</td> <td>Low complement levels</td> <td>No systemic involvement</td> </tr> <tr> <td><strong>DIF</strong></td> <td>Negative</td> <td>Negative</td> <td>Negative</td> <td>Negative</td> <td>Negative</td> <td>Negative</td> <td>+IgM</td> <td>+IgM</td> <td>IgA</td> <td>IgG, C3, fibrin, can also be seen along DEJ</td> <td>C3, IgM, IgA, IgG</td> </tr> </tbody></table></div><div class="graphic_footnotes">PAN: polyarteritis nodosa; c-PAN: cutaneous polyarteritis nodosa; NV: nodular vasculitis; GP (WG): granulomatosis with polyangiitis (Wegener's granulomatosis); EGP (CSS): eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome); MPA: microscopic polyangiitis; CV: cryoglobulinemic vasculitis; RV: rheumatoid arthritis; IgA (HSP): IgA vasculitis (Henoch-Schönlein purpura); UV: urticarial vasculitis; CSVV: cutaneous small vessel vasculitis; GI: gastrointestinal; p-ANCA: perinuclear antineutrophil cytoplasmic antibody; ANCA: antineutrophil cytoplasmic antibody; PPD: purified protein derivative; CXR: chest radiograph; PR3: proteinase-3; MPO: myeloperoxidase; DIF: direct immunofluorescence; IgM: immunoglobulin M; IgA: immunoglobulin A; IgG: immunoglobulin G; DEJ: dermal-epidermal junction.</div><div class="graphic_reference">Reference:<br/><ol>
<li>Carlson JA. The histological assessment of cutaneous vasculitis. Histopathology 2010; 56:3.</li>
</ol></div><div id="graphicVersion">Graphic 59048 Version 10.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
